Novo Nordisk, the leading Danish pharmaceutical company known for its production of insulin, has once again proven its dominance in the industry with its latest trading update. The company, which has become Europe’s largest by stock market value in the last year, surpassed investor expectations in both sales and profits. In its updated forecast, Novo Nordisk now expects sales growth to increase by…
